國立高雄大學圖資館 |

Language: English

Back

Practical pharmacology for Alzheimer...

Kudo, Takashi.

Practical pharmacology for Alzheimer's disease

Record Type:	Electronic resources : Monograph/item
Title/Author:	Practical pharmacology for Alzheimer's diseaseby Takashi Kudo ... [et al.].
other author:	Kudo, Takashi.
Published:	Cham :Springer International Publishing :2016.
Description:	viii, 141 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Alzheimer's disease.
Online resource:	http://dx.doi.org/10.1007/978-3-319-26206-2
ISBN:	9783319262062$q(electronic bk.)

Practical pharmacology for Alzheimer's disease
Practical pharmacology for Alzheimer's disease[electronic resource] /by Takashi Kudo ... [et al.]. - Cham :Springer International Publishing :2016. - viii, 141 p. :ill., digital ;24 cm.

Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

ISBN: 9783319262062$q(electronic bk.)

Standard No.: 10.1007/978-3-319-26206-2doiSubjects--Topical Terms:

229397
Alzheimer's disease.

LC Class. No.: RC523

Dewey Class. No.: 616.831

Practical pharmacology for Alzheimer's disease
LDR:02083nmm a2200313 a 4500 001 483495
003 DE-He213
005 20160822115934.0
006 m d
007 cr nn 008maaau
008 161007s2016 gw s 0 eng d
020 $a 9783319262062$q(electronic bk.)
020 $a 9783319262048$q(paper)
024 7 $a 10.1007/978-3-319-26206-2 $2 doi
035 $a 978-3-319-26206-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.831 $2 23
090 $a RC523 $b .P895 2016
245 0 0 $a Practical pharmacology for Alzheimer's disease $h [electronic resource] / $c by Takashi Kudo ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a viii, 141 p. : $b ill., digital ; $c 24 cm.
505 0 $a Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
520 $a The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
650 0 $a Alzheimer's disease. $3 229397
650 0 $a Alzheimer's disease $x Chemotherapy. $3 188753
650 0 $a Alzheimer's disease $x Treatment. $3 188756
650 0 $a Drugs $x Effectiveness. $3 680691
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Psychopharmacology. $3 252258
650 2 4 $a Neurology. $3 211583
650 2 4 $a Pharmacotherapy. $3 615025
700 1 $a Kudo, Takashi. $3 741068
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-26206-2
950 $a Medicine (Springer-11650)